Abnormal Uterine Bleeding (AUB)

An estimated 100 million women globally live with abnormal uterine bleeding (AUB).1 Eighty-eight percent of those women opt to wait and do not seek treatment immediately.([FOOTNOTE=Based on internal analysis of 2017 market model data. April 2018.],[ANCHOR=],[LINK=]) Yet, millions of them could alleviate their symptoms with hysteroscopy, especially when their AUB is likely caused by/could be caused by pathology such as endometrial polyps, fibroids or retained products of conception.

Visual D&C

A clear alternative to blind D&C

She deserves effective removal and accurate diagnosis of her intrauterine pathology. That’s why treatment without direct visualization should no longer be the norm.

With blind D&C, research shows:

  • Low diagnostic accuracy([FOOTNOTE=Epstein E, Ramirez A, Skoog L, Valentin L. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding. Acta Obstet Gynecol Scand. 2001;80(12):1131–1136.],[ANCHOR=],[LINK=])
  • Incomplete resection of pathology†,2,([FOOTNOTE=Bettocchi et al. Diagnostic Inadequacy of Dilatation & Curettage, Fertil Steril 2001;75:803-805.],[ANCHOR=],[LINK=])

Podcast Series

Better For Women: Contemporary OBGYN

Listen to Dr. Ido Sirota, MD, MHA, FACOG, the Division Director of Minimally Invasive Gynecologic Surgery and Robotics at New York-Presbyterian Queens. He specializes in advanced Minimally Invasive Gynecologic Surgery with focus on elevating gynecologic surgery by offering state-of-the-art surgical treatment for women.

  • † In a study of postmenopausal women, whole or parts of the lesion in situ after a D&C in 87% of patients.